These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 22839105)
1. Fludarabine and cladribine induce changes in surface proteins on human B-lymphoid cell lines involved with apoptosis, cell survival, and antitumor immunity. Kohnke PL; Mactier S; Almazi JG; Crossett B; Christopherson RI J Proteome Res; 2012 Sep; 11(9):4436-48. PubMed ID: 22839105 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive proteomic analysis of the effects of purine analogs on human Raji B-cell lymphoma. Mactier S; Henrich S; Che Y; Kohnke PL; Christopherson RI J Proteome Res; 2011 Mar; 10(3):1030-42. PubMed ID: 21182289 [TBL] [Abstract][Full Text] [Related]
3. Old and new insights into the mechanisms of action of two nucleoside analogs active in lymphoid malignancies: fludarabine and cladribine (review). Van den Neste E; Cardoen S; Offner F; Bontemps F Int J Oncol; 2005 Oct; 27(4):1113-24. PubMed ID: 16142330 [TBL] [Abstract][Full Text] [Related]
4. Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cells. Bouzar AB; Boxus M; Defoiche J; Berchem G; Macallan D; Pettengell R; Willis F; Burny A; Lagneaux L; Bron D; Chatelain B; Chatelain C; Willems L Br J Haematol; 2009 Jan; 144(1):41-52. PubMed ID: 19006566 [TBL] [Abstract][Full Text] [Related]
5. Bax expression correlates with cellular drug sensitivity to doxorubicin, cyclophosphamide and chlorambucil but not fludarabine, cladribine or corticosteroids in B cell chronic lymphocytic leukemia. Bosanquet AG; Sturm I; Wieder T; Essmann F; Bosanquet MI; Head DJ; Dörken B; Daniel PT Leukemia; 2002 Jun; 16(6):1035-44. PubMed ID: 12040435 [TBL] [Abstract][Full Text] [Related]
6. CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation. de Totero D; Tazzari PL; Capaia M; Montera MP; Clavio M; Balleari E; Foa R; Gobbi M Haematologica; 2003 Feb; 88(2):148-58. PubMed ID: 12604404 [TBL] [Abstract][Full Text] [Related]
7. CD154 expression triggered by purine analogues in vitro: Correlation with treatment response and autoimmune events in chronic lymphocytic leukemia. Citores MJ; Castejon R; Villarreal M; Rosado S; Garcia-Marco JA; Vargas JA Exp Hematol; 2010 Mar; 38(3):165-73. PubMed ID: 20026377 [TBL] [Abstract][Full Text] [Related]
8. Fludarabine induces differential expression of proteins in human leukemia and lymphoma cells. Henrich S; Gez S; Crossett B; Mulligan SP; Christopherson RI Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):634-40. PubMed ID: 18600519 [TBL] [Abstract][Full Text] [Related]
9. Nucleoside transporters, bcl-2 and apoptosis in CLL cells exposed to nucleoside analogues in vitro. Petersen AJ; Brown RD; Gibson J; Pope B; Luo XF; Schutz L; Wiley JS; Joshua DE Eur J Haematol; 1996 Apr; 56(4):213-20. PubMed ID: 8641389 [TBL] [Abstract][Full Text] [Related]
10. Role of poly(ADP-ribosyl)ation in the killing of chronic lymphocytic leukemia cells by purine analogues. Pettitt AR; Sherrington PD; Cawley JC Cancer Res; 2000 Aug; 60(15):4187-93. PubMed ID: 10945628 [TBL] [Abstract][Full Text] [Related]
11. Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro. Morabito F; Mangiola M; Rapezzi D; Zupo S; Oliva BM; Ferraris AM; Spriano M; Rossi E; Stelitano C; Callea V; Cutrona G; Ferrarini M Haematologica; 2003 Aug; 88(8):864-73. PubMed ID: 12935974 [TBL] [Abstract][Full Text] [Related]
12. Resveratrol increases rate of apoptosis caused by purine analogues in malignant lymphocytes of chronic lymphocytic leukemia. Podhorecka M; Halicka D; Klimek P; Kowal M; Chocholska S; Dmoszynska A Ann Hematol; 2011 Feb; 90(2):173-83. PubMed ID: 20714724 [TBL] [Abstract][Full Text] [Related]
13. Effects of the proteasome inhibitor, bortezomib, on apoptosis in isolated lymphocytes obtained from patients with chronic lymphocytic leukemia. Pahler JC; Ruiz S; Niemer I; Calvert LR; Andreeff M; Keating M; Faderl S; McConkey DJ Clin Cancer Res; 2003 Oct; 9(12):4570-7. PubMed ID: 14555532 [TBL] [Abstract][Full Text] [Related]
14. Assessment of peripheral blood and bone marrow cells apoptosis caused by purine analogues in patients with chronic lymphocytic leukemia in correlation with parameters of disease progression. Podhorecka M; Klimek P; Kowal M; Chocholska S; Bojarska-Junak A; Dmoszynska A Acta Haematol; 2010; 123(3):171-8. PubMed ID: 20224269 [TBL] [Abstract][Full Text] [Related]
15. In vitro modulation of bcl-2 protein expression, drug-induced apoptosis and cytotoxicity by interleukin-10 in chronic lymphocytic leukemia. Morabito F; Filangeri M; Sculli G; Oliva B Haematologica; 1998 Nov; 83(11):1046-8. PubMed ID: 9864930 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms of action of fludarabine nucleoside against human Raji lymphoma cells. Christopherson RI; Mactier S; Almazi JG; Kohnke PL; Best OG; Mulligan SP Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):375-83. PubMed ID: 24940695 [TBL] [Abstract][Full Text] [Related]
18. Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases. Chow KU; Sommerlad WD; Boehrer S; Schneider B; Seipelt G; Rummel MJ; Hoelzer D; Mitrou PS; Weidmann E Haematologica; 2002 Jan; 87(1):33-43. PubMed ID: 11801463 [TBL] [Abstract][Full Text] [Related]
19. Engagement of alpha4beta1 integrin by fibronectin induces in vitro resistance of B chronic lymphocytic leukemia cells to fludarabine. de la Fuente MT; Casanova B; Moyano JV; Garcia-Gila M; Sanz L; Garcia-Marco J; Silva A; Garcia-Pardo A J Leukoc Biol; 2002 Mar; 71(3):495-502. PubMed ID: 11867687 [TBL] [Abstract][Full Text] [Related]
20. Resistance to fludarabine-induced apoptosis in Epstein-Barr virus infected B cells. Fagard R; Mouas H; Dusanter-Fourt I; Devillers C; Bissières P; Martin A; Lenoir G; VanTan H; Feuillard J; Raphaël M Oncogene; 2002 Jul; 21(29):4473-80. PubMed ID: 12085225 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]